NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 215 filers reported holding NEVRO CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $214,952 | -71.3% | 8,456 | -18.4% | 0.03% | -66.2% |
| Q1 2022 | $749,000 | -1.6% | 10,359 | +10.4% | 0.08% | -2.4% |
| Q4 2021 | $761,000 | -56.1% | 9,387 | -37.0% | 0.08% | -38.3% |
| Q3 2021 | $1,734,000 | -33.2% | 14,898 | -19.9% | 0.13% | -40.9% |
| Q1 2021 | $2,594,000 | +871.5% | 18,594 | +1107.4% | 0.22% | +1025.0% |
| Q4 2020 | $267,000 | – | 1,540 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |